Dahan Biomedical Announces Board Resolution on 2026 First Quarter Earnings Distribution and Cash Dividend
Dahan Biomedical announced a cash dividend distribution for the first quarter of 2026. This includes approximately NT$0.116 per share from earnings surplus and NT$0.741 per share from capital reserve, totaling about NT$694 million in cash dividends.
📋 Article Processing Timeline
- 📰 Published: May 7, 2026 at 09:00
- 🔍 Collected: May 8, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 8, 2026 at 08:48 (48 min after Collected)
1. Date of board resolution: 2026/05/07
2. Fiscal year (quarter) to which the dividend belongs: 2026 Q1
3. Dividend period: 2026/01/01 to 2026/03/31
4. Shareholder distribution content:
(1) Cash dividend from earnings distribution (NT$/share): 0.11594660
(2) Cash from legal reserve distribution (NT$/share): 0
(3) Cash from capital reserve distribution (NT$/share): 0.74071864
(4) Total cash dividend distributed to shareholders (NT$): 693,919,552
(5) Stock dividend from earnings surplus (NT$/share): 0
(6) Stock dividend from legal reserve surplus (NT$/share): 0
(7) Stock dividend from capital reserve surplus (NT$/share): 0
(8) Total shares distributed to shareholders (shares): 0
5. Other matters to be specified: None
6. Par value per common share: NT$1.0000
2. Fiscal year (quarter) to which the dividend belongs: 2026 Q1
3. Dividend period: 2026/01/01 to 2026/03/31
4. Shareholder distribution content:
(1) Cash dividend from earnings distribution (NT$/share): 0.11594660
(2) Cash from legal reserve distribution (NT$/share): 0
(3) Cash from capital reserve distribution (NT$/share): 0.74071864
(4) Total cash dividend distributed to shareholders (NT$): 693,919,552
(5) Stock dividend from earnings surplus (NT$/share): 0
(6) Stock dividend from legal reserve surplus (NT$/share): 0
(7) Stock dividend from capital reserve surplus (NT$/share): 0
(8) Total shares distributed to shareholders (shares): 0
5. Other matters to be specified: None
6. Par value per common share: NT$1.0000